Flinders researchers have found proteins in lung fluid that could hold the key to diagnosing pleural mesothelioma months or even years before a tumour is visible on imaging scans.
The Flinders University scientists, some among the world’s leaders in mesothelioma research, examined proteins that help give rise to malignant pleural mesothelioma (MPM) and whether they could be used as biomarkers to identify the cancer earlier.
The new study published in the Journal of Proteomics notes that the incidence of mesothelioma is still increasing in many Western countries including Australia even though several of them have instituted asbestos bans.
This is largely because of mesothelioma’s long latency period which can sometimes be decades after initial asbestos exposure.
One of the reasons that asbestos cancer is so deadly is that it is usually not identified until it is in an advanced stage, making it less likely to respond to treatment. Many newly-diagnosed mesothelioma patients are told they have only months to live.
getstem.com.au/clues-to-ear...
Anatomical Pathology. Research Paper: